Skip to main content
Premium Trial:

Request an Annual Quote

Amersham Nabs Worldwide Rights to SurModics 3-D Array Slides

NEW YORK, Nov. 19 - Amersham Biosciences' purchase of Motorola's CodeLink business over the summer has also won Amersham exclusive worldwide rights to certain 3-D microarray slides made by SurModics, Amersham said today.

 

Amersham said it intends to market the slides, which have been renamed CodeLink Activated Slides.

 

The slides have a 3-dimensional surface that the company says can enhance the binding of nucleic acid and protein probes during the microarray-creation process.

 

No further information was given.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.